# clm_CA57488E244D

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_research_and_development  
value: 1,187,200,000 United States dollar  
valid_from: 2010-06-30  
valid_to: 2010-09-30  
published: 2010-08-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_49B945AD669C  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly research and development: 1,187,200,000 United States dollar", as of 2010-06-30 (until 2010-09-30). Claim clm_CA57488E244D, https://asof.is/claim/clm_CA57488E244D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000095012310070596/0000950123-10-070596-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q/A Q2 FY2010, filed 2010-08-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000095012310070596/0000950123-10-070596-index.htm (primary, SEC EDGAR 10-Q/A Q2 FY2010, published 2010-08-02)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_research_and_development | 1,039,100,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_CA57488E244D](/claim/clm_CA57488E244D.md) | [clm_0520A3172746](/claim/clm_0520A3172746.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.